DBX is processed by the Muskuloskeletal Transplant Foundation (MTF) and facilitated through Synthes.
DBX is an osteoinductive and osteoconductive bone graft substitute composed of demineralised bone matrix (DBM) from human donors in a sodium hyaluronate carrier. DBX is completely replaced by new host bone in a time ranging from 4 to 10 months. It features unique handling characteristics, is highly biocompatible due to the physiologic carrier and has a proven record of safety and efficacy based on a standardized manufacturing process.
Key Features & Benefits
- Osteoinductive and osteoconductive — for quick bone ingrowth and remodelling
- Remains contained at surgical site — does not wash away or migrate
- Ready to use — no preparation required
- Moldable to any size and shape — to precisely and completely fill irregular defects
- Biocompatible
Indications
- Bone void filler
- Critical size defects of long bones and pelvis
For non-load bearing indications only
A comprehensive portfolio of allograft products is available in certain countries depending on regional regulations.
For more detailed information about a specific product or availability of allografts please contact your local Synthes representative.
